HRES 803
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 12:16 PM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This resolution urges the Food and Drug Administration (FDA) to thoroughly re-examine the safety of chemical abortion drugs. It specifically requests the FDA to conduct a comprehensive review based on recent independent studies and to publicly share the findings, including data on real-world complications. The resolution expresses concerns about the expansion of access to these drugs and potential risks to women and girls, as well as the use of taxpayer funds in their provision. It also references research suggesting a higher rate of serious complications compared to reported figures.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.